SCHEMBL9284533

SCHEMBL9284533

COC(=O)c1ccccc1CCC(SCCC(=O)O)c1cccc(CCc2ccc3ccc(Cl)cc3n2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9281256 0.94 — —
SCHEMBL9208043 0.91 — —
SCHEMBL9221172 0.89 — —
SCHEMBL9689603 0.86 — —
SCHEMBL9689591 0.85 CYSLTR2 (0.56) —
SCHEMBL10590029 0.85 — —
SCHEMBL13015602 0.85 PLA2G2A (0.50) —
SCHEMBL12927207 0.85 PLA2G2A (0.50) —
SCHEMBL9200778 0.84 — —
SCHEMBL9200788 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5428033-A Useful as anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotecyive agents MERCK FROSST CANADA, INC. (CA) 1995-06-27 — — US disclosed
EP-0480716-A1 Saturated hydroxyalkylquinoline acids as leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1992-04-15 — — EP disclosed
Send feedback